FDA Inspection
Aspirus - Wausau HospitalAspirus - Wausau Hospital – FDA Inspection, Aug 31, 2018
Record Details
This FDA Inspection record concerns Aspirus - Wausau Hospital, with an inspection on August 31, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 1de2337f-66cf-4edf-bd55-f556ec348e7f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1064675
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Aspirus - Wausau Hospital
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 14, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 13, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 22, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 14, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 15, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Aspirus - Wausau Hospital
- FDA Inspection 1243567 - 2024-05-14
- FDA Inspection 958130 - 2016-01-13
- FDA Inspection 883477 - 2014-05-22
- FDA Inspection 756332 - 2011-11-14
- FDA Inspection 667432 - 2010-06-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.